|
Originally published In Press as doi:10.1074/jbc.M009596200 on April 19, 2001
J. Biol. Chem., Vol. 276, Issue 26, 23282-23287, June 29, 2001
Thioflavin T Is a Fluorescent Probe of the Acetylcholinesterase
Peripheral Site That Reveals Conformational Interactions between the
Peripheral and Acylation Sites*
Giancarlo V.
De Ferrari ,
William D.
Mallender§¶,
Nibaldo
C.
Inestrosa , and
Terrone L.
Rosenberry§
From the § Department of Pharmacology and Program in
Neurosciences, Mayo Foundation for Medical Education and Research, Mayo
Clinic Jacksonville, Jacksonville, Florida 32224 and the
Centro de Regulación Celular y Patología,
Departamento de Biología Celular y Molecular, Facultad de
Ciencias Biológicas, Pontificia Universidad Católica de
Chile, Alameda 340, 114-D Santiago, Chile
Received for publication, October 20, 2000, and in revised form, April 18, 2001
 |
ABSTRACT |
Three-dimensional structures of
acetylcholinesterase (AChE) reveal a narrow and deep active site gorge
with two sites of ligand binding, an acylation site at the base of the
gorge, and a peripheral site near the gorge entrance. Recent studies
have shown that the peripheral site contributes to catalytic efficiency
by transiently binding substrates on their way to the acylation site,
but the question of whether the peripheral site makes other
contributions to the catalytic process remains open. A possible role
for ligand binding to the peripheral site that has long been considered
is the initiation of a conformational change that is transmitted allosterically to the acylation site to alter catalysis. However, evidence for conformational interactions between these sites has been
difficult to obtain. Here we report that thioflavin T, a fluorophore
widely used to detect amyloid structure in proteins, binds selectively
to the AChE peripheral site with an equilibrium dissociation constant
of 1.0 µM. The fluorescence of the bound thioflavin
T is increased more than 1000-fold over that of unbound thioflavin T,
the greatest enhancement of fluorescence for the binding of a
fluorophore to AChE yet observed. Furthermore, when the acylation site
ligands edrophonium or m-(N,
N,N-trimethylammonio)trifluoroacetophenone form
ternary complexes with AChE and thioflavin T, the fluorescence is
quenched by factors of 2.7-4.2. The observation of this partial quenching of thioflavin T fluorescence is a major advance in the study
of AChE for two reasons. First, it allows thioflavin T to be used as a
reporter for ligand reactions at the acylation site. Second, it
indicates that ligand binding to the acylation site initiates a change
in the local AChE conformation at the peripheral site that quenches the
fluorescence of bound thioflavin T. The data provide strong evidence in
support of a conformational interaction between the two AChE sites.
 |
INTRODUCTION |
Acetylcholinesterase
(AChE)1 hydrolyzes the
neurotransmitter acetylcholine at extremely high catalytic rates (1).
Ligand binding studies (2) and x-ray crystallography (3) have revealed a narrow active site gorge some 20 Å deep with two separate
ligand binding sites. During catalytic hydrolysis, the substrate
acyl group is transferred briefly to residue
Ser-2002 in the
acylation site at the bottom of the gorge. This site contains residues
involved in a catalytic triad (His-440, Glu-327, Ser-200) and
Trp-84, which binds to the trimethylammonium group of acetylcholine. The peripheral site near the mouth of the gorge includes, among others,
residues Asp-72 and Trp-279. Recent investigations have shown that the
peripheral site contributes to catalytic efficiency by transiently
binding substrates on their way to the acylation site (4-6).
The question of whether the peripheral site plays additional roles in
the catalytic process has long been of interest. Changeux (7) was among
the first to appreciate that AChE contained two distinct ligand binding
sites and that there may be allosteric interactions between ligands
bound at these sites involving conformational changes in the protein
molecule. Ligands bound to the peripheral site can inhibit or
accelerate reactions at the acylation site, and these effects have
often been attributed to conformational interactions between the sites
(8, 9). However, direct evidence for such conformational interactions
has been difficult to obtain. For example, three-dimensional structures
of AChE complexes with two ligands specific for the acylation site,
edrophonium and the cationic trifluoromethylketone TMTFA, showed no
changes in the structure of the peripheral site (10, 11). In this
report we show that thioflavin T (Fig. 1)
binds specifically to the AChE peripheral site and is one of the most
useful fluorescent probes of AChE yet discovered. This fluorophore
frequently is used to detect amyloid structure in proteins (12), but
the three-dimensional structure of the AChE peripheral site shows no
indication of the extensive sheet structure characteristic of
amyloid. The intense fluorescence of thioflavin T bound to AChE is
partially quenched by the binding of acylation site ligands in ternary
complexes, and this quenching appears to result from a conformational
interaction between the two sites.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Recombinant human AChE (13) was purified as
outlined previously, and active site AChE concentrations were
determined by assuming 450 units/nmol
(6).3 Thioflavin T chloride
(Sigma) concentrations were assigned as 70% of the dry weight.
Thioflavin T chloride recrystallized from water gave an extinction
coefficient 412 nm of 36,000 M 1 cm 1. Concentrations of
propidium iodide (Calbiochem) were determined with an extinction
coefficient 493 nm of 5900 M 1 cm 1
(2), and concentrations of edrophonium chloride
(ethyl(3-hydroxyphenyl)dimethylammonium chloride; Sigma) were
determined with 271 nm of 3400 M 1 cm 1
from the dry weight (14). TMTFA (kindly provided by Dr. Daniel Quinn,
University of Iowa) concentrations were calibrated by titration with
AChE.
Steady State Inhibition of Enzyme-catalyzed Substrate
Hydrolysis--
Substrate hydrolysis rates were
measured in buffer (20 mM sodium phosphate and 0.02%
Triton X-100 at pH 7.0) at 25 °C after addition of small aliquots of
thioflavin T, acetylthiocholine, and
5,5'-dithiobis-(2-nitrobenzoic acid) (to a final concentration of 0.33 mM) in a total volume of 1.0 ml. An Ellman assay
(15) was used to measure formation of the thiolate dianion of
5,5'-dithiobis-(2-nitrobenzoic acid) at 412 nm ( 412
nm = 14.15 mM 1
cm 1; (16)) for 1-3 min on a Varian Cary 3A
spectrophotometer, and substrate concentrations were corrected for
substrate depletion resulting from hydrolysis during this interval. It
was assumed that acetylthiocholine concentrations were maintained at
low enough values (<1.0 mM) to ignore substrate inhibition
in the absence of inhibitors (4). In this case, a simplified scheme for
inhibition by peripheral site ligands is given in Scheme 1.
In this scheme, inhibitor (I) can bind to each of the three enzyme
species: E, ES, and EA. For
example, ESIP represents a ternary complex with
substrate (S) at the acylation site and I at the peripheral site
(denoted by the subscript P). The acylation rate constant
k2 is altered by a factor a in this
ternary complex. Reciprocal plots of  1
versus [S] 1 at all I concentrations here
were linear, a result consistent with Scheme 1 (4, 17), and slopes of
these plots were calculated by weighted linear regression analyses that
assumed that has a constant percent error. Plots of these slopes
versus inhibitor concentration were fitted to Equation 1 by
nonlinear regression analyses (Fig.P (BioSoft) version 6.0) with
slope values weighted by the reciprocal of their variance (17).
|
(Eq. 1)
|
KI is the equilibrium dissociation
constant for I with E, and the experimental parameter is
simply the ratio of the second order rate constant with saturating I to
that in the absence of I (17).
If thioflavin T (I1) can form a ternary complex with a second inhibitor
(I2) and AChE, the residual concentration of free enzyme
[E] in the presence of both inhibitors relative to the concentration of free enzyme ([E][I2]=0)
when only I1 is present is given by Equation 2 (18).
|
(Eq. 2)
|
In this equation, K1 is the equilibrium
dissociation constant for I1 with E,
K2 is the equilibrium dissociation constant for
I2 with E, and K12 is the equilibrium
dissociation constant for I1 with the EI2 complex. The
concentrations [E] and [E][I2] = 0 are proportional to the second order rate constants for
substrate hydrolysis. Their ratio here was estimated from the relative
at 19 µM acetylthiocholine, a concentration
sufficiently below the Kapp of 50 µM for acetylthiocholine (17), to justify the approximation that substrate hydrolysis was second order.
Fluorescence Determinations of the Binding of Thioflavin T and
Propidium to AChE--
The fluorescence of either thioflavin T or
propidium is enhanced when these ligands bind to the AChE peripheral
site. Fluorescence was monitored on a Perkin-Elmer LS-50B luminescence
spectrometer in 20 mM sodium phosphate buffer (pH 7.0) and
0.02% Triton X-100 thermostated at 23 ± 1 °C. Thioflavin T
fluorescence was measured with excitation at 450 nm and emission from
470 to 500 nm with excitation and emission slits of 10 nm. Propidium
fluorescence was monitored with excitation at 500 nm and emission from
590 to 630 nm with slits of 10 nm (2, 18). Total areas under the
fluorescence emission curves (F) were calculated (unless otherwise noted), and fluorescence contributions from scatter in the buffer and
enzyme were subtracted.
In some experiments values of F were fitted by nonlinear regression
analysis (Fig.P) to Equation 3 (18).
|
(Eq. 3)
|
In Equation 3, fL is the fluorescence
intensity coefficient for free ligand, fEL is
the fluorescence intensity coefficient for bound ligand,
Etot is the total enzyme concentration,
Ltot is the total ligand concentration,
KD is the equilibrium dissociation constant, and
D = Etot + Ltot + KD. Data were fitted by nonlinear regression
analysis (Fig.P) to Equation 3, either with Ltot as the
independent variable and Etot fixed or with the
calculated Etot as the independent variable and
Ltot fixed, to give KD,
fEL, and in some cases
fL. In these analyses, values of F were weighted
by assuming constant percent error.
In other experiments, Scheme 2 was employed to evaluate interactions in
ternary complexes involving thioflavin T and a second ligand in
fluorescence assays. In this scheme the affinity of thioflavin T (L) at
the peripheral site (denoted by subscript P) of AChE (E) is
characterized by the dissociation constant KL in
the absence of an acylation site ligand (I) and by
KL2 when I occupies the acylation site. When I
was edrophonium, the binding of I to E and
ELP was assumed to reach equilibrium
instantaneously with dissociation constants KI and
KI2, respectively. Binding of I to E
and ELp was much slower when I was TMTFA
and occurred with association rate constants kI
and kI2 and dissociation rate constants
k I and k I2,
respectively. The program SCoP (Simulation Resources, Inc., Redlands,
CA; version 3.51) was applied directly to the rate equations
corresponding to Scheme 2 (17). This program solves differential
equations with numerical solvers and allowed fitting of F at various
inhibitor concentrations and/or times. The total concentrations
Etot, Ltot, and Itot, as well as fL, were inserted into the program as
fixed input parameters. With edrophonium, the program simultaneously
fit the fluorescence areas F to the edrophonium concentrations to
determine five parameters: the three equilibrium constants
(KL, KI, and
KL2), fEL, and
fEIL, the fluorescence intensity coefficient for
the ternary complex. With TMTFA, KI also was
fixed, and the program simultaneously fit the time courses of
fluorescence emission intensity at 480 nm (F480) to the
time after mixing to determine KL,
KL2, fEL, and
fEIL plus two additional parameters,
kI and kI2.
 |
RESULTS |
Thioflavin T Inhibits Substrate Hydrolysis by AChE in a Manner
Similar to Other Peripheral Site Inhibitors--
A conventional steady
state analysis of thioflavin T inhibition of AChE is shown in Fig.
2. Increasing concentrations of
thioflavin T increase the slopes of the reciprocal plots in Fig.
2A, and a plot of these slopes versus thioflavin
T concentration shows a slight curvature (Fig. 2B),
consistent with a nonzero value of in Equation 1. In the classical
equilibrium analysis of Scheme 1, is
less than 1 when aKS/KS2 < 1. However, we have recently shown that a nonequilibrium analysis
provides a more accurate interpretation, and in this analysis is
less than 1 when kS2 < kS (17). The substrate association rate constant
kS2 becomes smaller than
kS when the bound peripheral site ligand slows
the entry of substrate to the acylation site, an effect we have termed steric blockade. The value of of 0.05 obtained for thioflavin T
here is similar to those found for the prototypic peripheral site
inhibitors propidium and gallamine ( = 0.02) (17), indicating that with bound thioflavin T
kS2/kS is less than 0.05. In addition to demonstrating a substantial steric blockade by
thioflavin T, the data in Fig. 2 indicate a competitive inhibition
constant KI for thioflavin T of 0.90 µM.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Steady state inhibition of AChE hydrolysis by
thioflavin T. A, reciprocal plots of initial velocities
( A412 nm/min) and acetylthiocholine
concentrations were analyzed by linear regression analysis. Thioflavin
T concentrations were 0 ( ), 1 µM ( ), and 5 µM ( ). B, the slopes of plots in
A were normalized by dividing by the slope in the absence of
inhibitor and plotted against the inhibitor concentration according to
Equation 1 to derive KI = 0.90 ± 0.13 µM and = 0.05 ± 0.03.
|
|
Thioflavin T Binds to the Peripheral Site, and Its Affinity Is Not
Altered by the Binding of Edrophonium to the Acylation Site--
To
demonstrate that thioflavin T binds to the peripheral site, we measured
the ability of two ligands to competitively inhibit thioflavin T
binding in a substrate hydrolysis assay (18). Propidium is specific for
the AChE peripheral site (2), whereas edrophonium is specific for the
AChE acylation site (10), and both inhibited substrate hydrolysis in
the absence of thioflavin T, as shown by the open circles
and dashed lines in Fig. 3. If
either of these ligands was completely competitive with thioflavin T
such that no ternary complex could form, the decrease in would
correspond to the dotted lines in Fig. 3. This is
essentially the case with propidium in Fig. 3A. The affinity
of thioflavin T in the ternary complex decreased by a factor of 35 relative to its affinity in the free enzyme, a large change that was
not significantly different from complete competition at the ligand
concentrations employed. In contrast, the affinity of thioflavin T was
no different in the ternary complex with edrophonium and in the free
enzyme, and the fitted line with both inhibitors was
superimposed on the dashed line for edrophonium alone in
Fig. 3B. These data indicate that thioflavin T binds to the
AChE peripheral site in a fashion that is essentially competitive with
propidium.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
Determination of the relative affinity of
thioflavin T in the propidium-AChE complex (A) or the
edrophonium-AChE complex (B) by inhibition of
substrate hydrolysis. Mixtures of AChE ( , 25 pM;
, 200 pM), the indicated concentration of propidium or
edrophonium without ( ) or with ( ) thioflavin T (20 µM), 5,5'-dithiobis-(2-nitrobenzoic acid), and 20 µM acetylthiocholine were assayed over a 3-4-min
interval. Hydrolysis rates were normalized by the corresponding obtained at the same thioflavin T concentration in the absence of
propidium ( [prop]=0) or edrophonium
( [edro]=0). Lines correspond to normalized
obtained by fitting the experimental data to Equation 2. In these
analyses K1 for thioflavin T was assumed to be
1.0 µM (from Fig. 1). From the fitted curves without
thioflavin T (dashed lines), K2 for
propidium was determined to be 1.87 ± 0.09 µM, and
K2 for edrophonium was determined to be 335 ± 14 nM. Ratios of
K12/K1 from the
fitted curves with 20 µM thioflavin T (solid
lines) were 35 ± 9 with propidium and 1.01 ± 0.05 with
edrophonium. The dotted lines correspond to the curves
calculated when no ternary complex forms (1/K12 = 0).
|
|
The Fluorescence Enhancement of Thioflavin T Bound to AChE Is Much
Larger than That of Propidium Bound to AChE--
The fluorescence of
thioflavin T was strikingly enhanced when it bound to AChE. An
excitation peak at 448 nm and an emission peak at 486 nm became
apparent, spectral characteristics similar to those of thioflavin T
bound to A amyloid (excitation maximum at 448 nm; emission maximum
at 480 nm) (also see Ref. 12). To appreciate the fluorescence
enhancement of thioflavin T when bound to the peripheral site of AChE,
we compared it to the fluorescence enhancement observed with propidium
bound to AChE. Prior to this report, propidium has been the fluorophore
with the best reported fluorescence enhancement with AChE, and it is
widely used as a reporter of ligand affinity at the AChE peripheral
site (2, 9, 18). However, when AChE was titrated with varying
concentrations of the two fluorophores (Fig.
4), the fluorescence enhancement fEL/fL for thioflavin T
bound to AChE was greater than 1000, whereas that for propidium was
about 7 (in agreement with a value of 10 obtained for propidium with
Torpedo AChE (19)). Clearly, thioflavin T will be a more
sensitive and versatile fluorescent reporter of ligand interactions
with AChE than propidium has been. The titration in Fig. 4A
also gave a KD for thioflavin T binding of 0.89 µM, in good agreement with the KI
obtained in Fig. 2. Repeating this titration and analysis with a higher
fixed concentration of AChE (10 µM) confirmed a 1:1
stoichiometry in the AChE-thioflavin T fluorescent complex (data not
shown). Titrations also were conducted with a fixed concentration of
thioflavin T (0.2 µM) and varying concentrations of AChE
(10 nM-20 µM), and analysis with Equation 3
(18) again indicated a KD of 0.8-0.9
µM (data not shown). Propidium (100 µM) was
strongly competitive with thioflavin T in this titration protocol,
because the apparent KD for thioflavin T increased
by at least a factor of 50.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 4.
Fluorescence titrations of AChE with
thioflavin T (A) and propidium
(B). Fluorescence values (F) were measured as
outlined under "Experimental Procedures" at the indicated
concentration of ligand (Ltot). The fluorescence intensity
coefficients for the free ligands (fF) were
obtained from the slope of F versus Ltot in the
absence of AChE ( ). The fluorescence F in the presence of a fixed
concentration of AChE (0.87 µM) ( ) was then fitted to
Equation 3 to obtain the fluorescence intensity coefficient for bound
ligand (fEL) and KD for the
ligand-AChE complex. For thioflavin T, KD = 0.89 ± 0.05 µM and
fEL/fL = 1300 ± 100; for propidium, KD = 2.4 ± 0.9 µM and
fEL/fL = 6.9 ± 1.5.
|
|
The Binding of Acylation Site Ligands to the AChE-Thioflavin T
Complex Decreases the Fluorescence Enhancement of Bound Thioflavin
T--
According to Fig. 3B, a ternary complex of
thioflavin T and edrophonium can form with AChE without a loss in
affinity of either ligand for its AChE site. We therefore asked whether
the binding of an acylation site ligand altered the fluorescence of
bound thioflavin T. We first examined the effect of increasing
edrophonium concentrations and observed a decrease in the fluorescence
as edrophonium saturated the acylation site (Fig.
5). Fitting of the data to Scheme
2 gave values of
KL for thioflavin T and
KI for edrophonium that were in agreement with
those from Figs. 2-4 and again indicated almost no change in the
affinities of these ligands for AChE in the ternary complex
(KL2/KL = 1.12 ± 0.02, in agreement with
K12/K1 = 1.01 ± 0.05 from Fig. 3B). However, the binding of edrophonium
decreased the fluorescence of thioflavin T in the ternary complex by a
factor of 2.8. The observation of this partial quenching of thioflavin
T fluorescence is a major advance in the study of AChE for two reasons.
First, it allows thioflavin T to be used as a reporter for ligand
reactions at the acylation site. Second, it indicates that ligand
binding to the acylation site alters the environment or the
configuration of thioflavin T bound to the peripheral site, a point
that we return to below.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Edrophonium binding decreases the
fluorescence of AChE-bound thioflavin T. The fluorescence values
(F) of mixtures of AChE (182 ± 20 nM), thioflavin T
( , 10 µM; , 3 µM; , 1 µM), and the indicated concentration of edrophonium were
determined. The fluorescence intensity coefficient for free thioflavin
T (fL) was taken from Fig. 4 (8.8 units/µM), and F values from all three data sets were
fitted with the SCoP program simultaneously, as outlined under
"Experimental Procedures." The fitting gave
KL = 1.08 ± 0.03 µM for
thioflavin T, KI = 250 ± 10 nM
for edrophonium, KL2/KL = 1.12 ± 0.02, fEL/fL = 1600 ± 200, and
fEL/fEIL = 2.76 ± 0.02. Most of the standard error magnitudes arose from uncertainty in
the AChE concentrations.
|
|
To illustrate the first point we examined TMTFA, which forms a
hemiketal with Ser-200 in the acylation site that is an analog of the
transition state formed by acetylcholine (11, 20, 21). The high
affinity of TMTFA in this complex allows the time course of its binding
to be monitored over a wide range of TMTFA concentrations. Fluorescence
traces for nine combinations of TMTFA and thioflavin T concentrations
were recorded, and three representative reactions are shown in Fig.
6. The nine reaction time courses were
fitted simultaneously to Scheme 2 with the SCoP program. Over this
range of association rates the TMTFA concentrations were too high to evaluate KI for TMTFA; so
KI was fixed at 49 pM as determined previously (17), and six remaining parameters were determined. A wealth
of information was obtained. First, a KL of 1.0 µM for thioflavin T and an enhancement in fluorescence of
bound thioflavin T
(fEL/fL) of 1600 were
obtained, consistent with data in Figs. 4 and 5. Second, the affinities
of thioflavin T and TMTFA in the ternary complex with AChE were at
least as high as the affinities in their respective binary complexes
(KL2/KL = KI2/KI = 0.56), in
agreement with the previous observations for edrophonium in Figs. 3 and
5. Third, steric blockade of TMTFA binding by bound thioflavin T was
evident (kI/kI2 = 60),
although the magnitude of the blockade was somewhat smaller than the
nearly 400-fold decrease in association rate constant for TMTFA when
propidium was bound to the peripheral site (17). Fourth, the binding of TMTFA decreased the fluorescence of thioflavin T in the ternary complex
by a factor of 4.2. The extent of this quenching appears to be somewhat
larger than that observed with edrophonium in Fig. 5, suggesting that
the quenching of bound thioflavin T in ternary complexes with AChE may
depend on the structure of the acylation site ligand. A quenching
smaller than that obtained with either edrophonium or TMTFA was
observed when Ser-200 was acylated with a methylethoxyphosphonyl group
(data not shown), indicating that the acylation site ligand need not be
cationic to quench the fluorescence of bound thioflavin T.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Thioflavin T fluorescence monitors the
binding of TMTFA to the AChE acylation site. Reactions were
initiated by addition of TMTFA (1, 3, or 10 µM final
concentration) to a mixture of AChE (182 ± 20 nM) and thioflavin T (1, 3, or 10 µM) and
immediately transferred to the fluorometer, where the emission was
monitored at 480 nm (F480), as outlined under
"Experimental Procedures." The time courses of F480 for
each of the nine combinations of TMTFA and thioflavin T were fitted
with the SCoP program simultaneously, as outlined under "Experimental
Procedures" with KI for TMTFA fixed at 49 pM (17). The fitting gave the following:
KL = 1.0 µM for thioflavin T;
KL2/KL = 0.56;
fEL/fL = 1600;
fEL/fEIL = 4.2;
kI = 3.1 µM 1m 1;
and kI/kI2 = 60. Shown
are the three time courses observed at 10 µM thioflavin T
and 1 µM (upper solid line), 3 µM (middle solid line), and 10 µM (lower solid line) TMTFA and the
corresponding fitted lines (dotted).
|
|
 |
DISCUSSION |
The discovery that the fluorescence of the AChE-thioflavin T
complex is partially quenched when a ligand binds to the acylation site
is of both practical and conceptual importance. In practical terms,
this fluorescence change can be monitored to report on reactions at the
acylation site. We illustrate this with TMTFA in Fig. 6, but similar
protocols should allow the reactions of acylating agents like
organophosphates to be measured over time courses as short as
milliseconds. Conceptually, the partial quenching on the binding of
acylation site ligands is the strongest evidence to date of
conformational interaction between the peripheral and acylation sites
of AChE. Although such conformational interaction has been widely
invoked to account for a range of experimental data, close analysis
indicates that previous evidence for such interactions is inconclusive.
A frequent assertion is that ligand binding to the peripheral site
alters the conformation of the acylation site to reduce the efficiency
of acylation or deacylation by substrates. This explanation has been
offered to account for inhibition of substrate hydrolysis by peripheral
site ligands (9) and, when the substrate itself can bind to the
peripheral site, for substrate inhibition at high substrate
concentrations (22). As noted by Taylor and Radic (23), ligand
association with the peripheral site also may prevent access of a
cationic substrate to the acylation site by physically obstructing
substrate entry or by charge repulsion between ligand and substrate.
Before an allosteric interaction can be invoked, contributions from
these other factors must be eliminated. Over the past 3 years, we have
demonstrated that bound peripheral site ligands do physically obstruct
the entry of substrates as well as of other ligands into the acylation
site. Bound propidium decreases the association and dissociation rate
constants for the acylation site ligands huperzine A and TMTFA by
factors of 10-400. We have termed this effect steric blockade (17) and shown that similar decreases in the association rate constants for
substrates and the dissociation rate constants for the alcohol products
of substrate hydrolysis (e.g. thiocholine) are sufficient to
account for the inhibition of substrate hydrolysis by peripheral site
ligands (4, 17) as well as for substrate inhibition (4). Steric
blockade in our terminology is strictly a kinetic effect, and it can
have no influence on substrate affinity or hydrolysis by slowly
reacting substrates like organophosphates that equilibrate with AChE
before acylation. However, 5- to 10-fold decreases in organophosphate
affinity for propidium-bound AChE were observed with both a cationic
and a neutral organophosphate, indicating an additional type of
interaction (6, 13). Molecular modeling calculations indicate that an
organophosphate with a large leaving group would overlap with propidium
if both ligands were placed in their expected sites in free AChE (13),
and we have attributed these decreases in affinity to adjustments that accommodate both ligands in the ternary complex (6, 13). Modeling
calculations indicate that such steric overlap is not a factor in
ternary complexes involving propidium-AChE and either huperzine A or
TMTFA; yet ligand affinities in the ternary complexes also are 5- to
7-fold lower than in the corresponding binary complexes (17). We have
suggested that the decreased affinities arise from electrostatic
interactions between these cationic ligands (17). In summary,
experimental data indicate that the binding of a peripheral site ligand
to AChE can result in steric blockade, steric overlap, and/or
electrostatic interaction that inhibits substrate hydrolysis or
reduces ligand affinity at the acylation site. With small peripheral
site ligands like propidium and gallamine, we see no evidence of an
additional allosteric conformational effect that contributes to inhibition.
More compelling indications of conformational interaction between the
peripheral and acylation sites of AChE have come from two other
experimental approaches. First, the spectral properties of a
pyrenebutyl methylphosphono group attached to Ser-200 in the acylation
site are altered slightly by the binding of gallamine to the peripheral
site (24). The authors attributed these alterations to an increase in
polarizability of the pyrenebutyl environment, perhaps due to torsional
movements of aromatic side chains in the vicinity of the pyrenebutyl
moiety induced by the binding of the peripheral site ligand. Second,
bound peripheral site ligands can accelerate the reaction of acylating
agents with Ser-200 in the acylation site. Gallamine accelerated the
acylation of AChE by dimethylcarbamyl fluoride (25), and peripheral
site inhibitors including propidium and gallamine increased the first
order phosphorylation rate constants for neutral organophosphates with
AChE (6, 13, 26). This rate constant reflects the transfer of the
organophosphate group to Ser-200 in the binary or ternary complexes
(equivalent to k2 and
ak2, respectively, in Scheme 1). Before these
effects can be attributed to a conformational change in the acylation site induced by ligand binding to the peripheral site, however, other
explanations again must be eliminated. Foremost among alternative explanations is steric overlap as denoted above. One of the neutral organophosphates with accelerated first order phosphorylation when
propidium is bound was also shown by molecular modeling to bind with
AChE in a way that partially overlapped with the propidium binding site
(13). We have argued that movement of the organophosphate to eliminate
this overlap in the ternary complex could potentially induce strain in
the bond to the organophosphate leaving group and thereby increase the
phosphorylation rate constant (6). In like fashion, preliminary
molecular modeling suggests that the pyrenebutyl methylphosphono group
attached to Ser-200 is bulky enough to overlap partially with the
peripheral site. Although the affinities of gallamine and propidium
were similar for this modified AChE and for free AChE, a large
thermodynamic interaction between the ligands is not necessary for
there to be spectral changes due to the ligand proximity. Steric
overlap thus remains a concern when conformational interactions between
the peripheral and acylation sites are proposed. However, several pairs
of peripheral site ligands and organophosphates (some with quite small
leaving groups) showed the acceleration phenomenon (26). Because steric overlap is unlikely to generate the acceleration in all of these cases,
it appears reasonable to infer a conformational change that promotes
phosphorylation on ligand binding to the peripheral site.
Our data here are the first to indicate that ligand binding to the
acylation site can alter the conformation of the peripheral site. The
partial quenching of the fluorescence of bound thioflavin T when a
ligand binds to the acylation site cannot result from fluorescence
resonance energy transfer, because there is no spectral overlap between
thioflavin T and either of the acylation site ligands edrophonium or
TMTFA. However, the fluorescence of thioflavin T has been shown to
depend on solvent viscosity (27), with a relationship previously
described for a class of fluorescent dyes called molecular rotors (28,
29). These dyes show increased fluorescence when introduced into high
viscosity media, due to a decreased torsional relaxation. Binding to
the AChE peripheral site could reduce the torsional mobility of
thioflavin T and account for its enhanced fluorescence. It is less
clear how the binding of an acylation site ligand could partially
quench this fluorescence in the ternary complex, but the quenching
would appear to require an increase in the torsional mobility of bound
thioflavin T induced by a change in the local AChE conformation that is
initiated in the acylation site. The exact location of thioflavin T
when bound to the AChE peripheral site remains to be determined, but it
is unlikely that simple proximity to the acylation site ligand could account for the quenching. Crystal structures of bound edrophonium and
bound TMTFA show that both ligands bind near the base of the acylation
site, well away from the region that defines the peripheral site (10,
11). Furthermore, these ligands show no decrease in affinity in their
ternary complexes with propidium-AChE, indicating no steric overlap.
Ideally, one would like to support this proposed conformational
interaction with additional data, but the conformational changes
involved appear to be very small. Crystal structures of AChE and the
TMTFA-AChE complex show a root mean square deviation of only 0.4 Å between equivalent C positions and no changes in the
structure of the peripheral site (11). Electron paramagnetic resonance
of AChE labeled with a spin-labeled organophosphate at Ser-200 gave no
change in signal when propidium was bound to the peripheral site,
although a small change was observed with monoclonal antibodies or the
neurotoxin fasciculin, both of which bind to a larger surface area
extending beyond the peripheral site (30). Therefore, we conclude that
the quenching of the fluorescence of AChE-bound thioflavin T by
acylation site ligands is the only method to date that is sensitive
enough to reveal a conformational interaction between the two sites.
This interaction may provide a mechanism for bound peripheral site
ligands to accelerate acylation site reactions.
 |
ACKNOWLEDGEMENTS |
We express our gratitude to Samuel Pickett
for maintenance of cell cultures and purification of recombinant human
AChE and to Dr. Joseph Johnson and Matthew Davies for assistance with
TMTFA reactions.
 |
FOOTNOTES |
*
This work was supported by Grant NS-16577 from the National
Institutes of Health, Grant DAMD 17-98-2-8019 from the United States
Army Medical Research Acquisition Activity, grants from the Muscular
Dystrophy Association of America (to T. L. R.), Grant FONDAP N
13980001 and a Presidential Chair in Science from the Chilean
Government (to N. C. I.), and Grant FONDECYT N 4000030 (to
G. V. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Current address: Millennium Pharmaceuticals, Inc., Cambridge,
MA 02139.
To whom correspondence should be addressed. Tel.:
904-953-7375; Fax: 904-953-7370; E-mail: rosenberry@mayo.edu.
Published, JBC Papers in Press, April 19, 2001, DOI 10.1074/jbc.M009596200
2
Throughout this paper we number residues
according to the Torpedo AChE sequence. For example,
Trp-84 and Ser-200 in this sequence correspond to Trp-86 and Ser-203,
respectively, in mammalian AChE.
3
One unit of AChE activity corresponds to 1 umol
of acetylthiocholine hydrolyzed/min under standard pH-stat assay
conditions, and these conditions correspond to maximal AChE activity at
pH 8 (31). Our conventional spectrophotometric assay at 412 nm is
conducted in pH 7 buffer with 0.5 mM acetylthiocholine,
conditions that result in 4.8 A412 nm/min
with 1 nM AChE (or about 76% of the maximal activity).
 |
ABBREVIATIONS |
The abbreviations used are:
AChE, acetylcholinesterase;
TMTFA, m-(N,N,N-trimethylammonio)trifluoroacetophenone.
 |
REFERENCES |
| 1.
|
Rosenberry, T. L.
(1975)
in
Advances in Enzymology
(Meister, A., ed), Vol. 43
, pp. 103-218, John Wiley & Sons, Inc., New York
|
| 2.
|
Taylor, P.,
and Lappi, S.
(1975)
Biochemistry
14,
1989-1997
|
| 3.
|
Sussman, J. L.,
Harel, M.,
Frolow, F.,
Oefner, C.,
Goldman, A.,
Toker, L.,
and Silman, I.
(1991)
Science
253,
872-879
|
| 4.
|
Szegletes, T.,
Mallender, W. D.,
Thomas, P. J.,
and Rosenberry, T. L.
(1999)
Biochemistry
38,
122-133
|
| 5.
|
Tara, S.,
Elcock, A. H.,
Kirchhoff, P. D.,
Briggs, J. M.,
Radic, Z.,
Taylor, P.,
and McCammon, J. A.
(1998)
Biopolymers
46,
465-474
|
| 6.
|
Mallender, W. D.,
Szegletes, T.,
and Rosenberry, T. L.
(2000)
Biochemistry
39,
7753-7763
|
| 7.
|
Changeux, J.-P.
(1966)
Mol. Pharmacol.
2,
369-392
|
| 8.
|
Hucho, F.,
Jarv, J.,
and Weise, C.
(1991)
Trends Pharmacol. Sci.
12,
422-426
|
| 9.
|
Barak, D.,
Ordentlich, A.,
Bromberg, A.,
Kronman, C.,
Marcus, D.,
Lazar, A.,
Ariel, N.,
Velan, B.,
and Shafferman, A.
(1995)
Biochemistry
34,
15444-15452
|
| 10.
|
Harel, M.,
Schalk, I.,
Ehret-Sabatier, L.,
Bouet, F.,
Goeldner, M.,
Hirth, C.,
Axelsen, P. H.,
Silman, I.,
and Sussman, J. L.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
9031-9035
|
| 11.
|
Harel, M.,
Quinn, D. M.,
Nair, H. K.,
Silman, I.,
and Sussman, J. L.
(1996)
J. Am. Chem. Soc.
118,
2340-2346
|
| 12.
|
LeVine, H., III
(1999)
in
Methods in Enzymology
(Wetzel, R., ed), Vol. 309
, pp. 274-284, Academic Press, Orlando, FL
|
| 13.
|
Mallender, W. D.,
Szegletes, T.,
and Rosenberry, T. L.
(1999)
J. Biol. Chem.
274,
8491-8499
|
| 14.
|
Sharp, T. R.,
and Rosenberry, T. L.
(1982)
J. Biochem. Biophys. Methods
6,
159-172
|
| 15.
|
Ellman, G. L.,
Courtney, K. D.,
Andres, J. V.,
and Featherstone, R. M.
(1961)
Biochem. Pharmacol.
7,
88-95
|
| 16.
|
Riddles, P. W.,
Blakeley, R. L.,
and Zerner, B.
(1979)
Anal. Biochem.
94,
75-81
|
| 17.
|
Szegletes, T.,
Mallender, W. D.,
and Rosenberry, T. L.
(1998)
Biochemistry
37,
4206-4216
|
| 18.
|
Camps, P.,
Cusack, B.,
Mallender, W. D.,
El Achab, R.,
Morral, J.,
Muñoz-Torrero, D.,
and Rosenberry, T. L.
(2000)
Mol. Pharmacol.
57,
409-417
|
| 19.
|
Taylor, P.,
Lwebuga-Mukasa, J.,
Lappi, S.,
and Rademacher, J.
(1974)
Mol. Pharmacol.
10,
703-708
|
| 20.
|
Brodbeck, U.,
Schweikert, K.,
Gentinetta, R.,
and Rottenberg, M.
(1979)
Biochim. Biophys. Acta
567,
357-369
|
| 21.
|
Nair, H. K.,
Lee, K.,
and Quinn, D. M.
(1993)
J. Am. Chem. Soc.
115,
9939-9941
|
| 22.
|
Radic, Z.,
Reiner, E.,
and Taylor, P.
(1991)
Mol. Pharmacol.
39,
98-104
|
| 23.
|
Taylor, P.,
and Radic, Z.
(1994)
Annu. Rev. Pharmacol. Toxicol.
34,
281-320
|
| 24.
|
Berman, H. A.,
Becktel, W.,
and Taylor, P.
(1981)
Biochemistry
20,
4803-4810
|
| 25.
|
Kitz, R. J.,
Braswell, L. M.,
and Ginsburg, S.
(1970)
Mol. Pharmacol.
6,
108-121
|
| 26.
|
Radic, Z.,
and Taylor, P.
(1999)
Chem. Biol. Interact.
119-120,
111-117
|
| 27.
|
Friedhoff, P.,
Schneider, A.,
Mandelkow, E.-M.,
and Mandelkow, E.
(1998)
Biochemistry
37,
10223-10230
|
| 28.
|
Kung, C. E.,
and Reed, J. K.
(1986)
Biochemistry
25,
6114-6121
|
| 29.
|
Loutfy, R. O.,
and Arnold, B. A.
(1982)
J. Phys. Chem.
86,
4205-4211
|
| 30.
|
Sentjurc, M.,
Pecar, S.,
Stojan, J.,
Marchot, P.,
Radic, Z.,
and Grubic, Z.
(1999)
Biochim. Biophys. Acta
1430,
349-358
|
| 31.
|
Rosenberry, T. L.,
and Scoggin, D. M.
(1984)
J. Biol. Chem.
259,
5643-5652
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Rajasekaran, N. P. Sastri, J. R. Marathahalli, S. S. Indi, K. Pamidimukkala, K. Suguna, and C. D. Rao
The flexible C terminus of the rotavirus non-structural protein NSP4 is an important determinant of its biological properties
J. Gen. Virol.,
June 1, 2008;
89(6):
1485 - 1496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Sultatos
Concentration-Dependent Binding of Chlorpyrifos Oxon to Acetylcholinesterase
Toxicol. Sci.,
November 1, 2007;
100(1):
128 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Rosenfeld and L. G. Sultatos
Concentration-Dependent Kinetics of Acetylcholinesterase Inhibition by the Organophosphate Paraoxon
Toxicol. Sci.,
April 1, 2006;
90(2):
460 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Jagannath, M. M. Kesavulu, R. Deepa, P. N. Sastri, S. S. Kumar, K. Suguna, and C. D. Rao
N- and C-Terminal Cooperation in Rotavirus Enterotoxin: Novel Mechanism of Modulation of the Properties of a Multifunctional Protein by a Structurally and Functionally Overlapping Conformational Domain
J. Virol.,
January 1, 2006;
80(1):
412 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Bourne, H. C. Kolb, Z. Radic, K. B. Sharpless, P. Taylor, and P. Marchot
Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation
PNAS,
February 10, 2004;
101(6):
1449 - 1454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nicolet, O. Lockridge, P. Masson, J. C. Fontecilla-Camps, and F. Nachon
Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products
J. Biol. Chem.,
October 17, 2003;
278(42):
41141 - 41147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Johnson, B. Cusack, T. F. Hughes, E. H. McCullough, A. Fauq, P. Romanovskis, A. F. Spatola, and T. L. Rosenberry
Inhibitors Tethered Near the Acetylcholinesterase Active Site Serve as Molecular Rulers of the Peripheral and Acylation Sites
J. Biol. Chem.,
October 3, 2003;
278(40):
38948 - 38955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shi, A. E. Boyd, Z. Radic, and P. Taylor
Reversibly Bound and Covalently Attached Ligands Induce Conformational Changes in the Omega Loop, Cys69-Cys96, of Mouse Acetylcholinesterase
J. Biol. Chem.,
November 2, 2001;
276(45):
42196 - 42204.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|